echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > JAMA Neurology-Tiantan Hospital’s new discovery: For moderate ischemic stroke, there is no difference in the effect of ticagrelor and aspirin combined with aspirin alone

    JAMA Neurology-Tiantan Hospital’s new discovery: For moderate ischemic stroke, there is no difference in the effect of ticagrelor and aspirin combined with aspirin alone

    • Last Update: 2021-07-27
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Dual antiplatelet therapy (DAPT) is a key strategy for early treatment of minor non-myocardial infarction ischemic stroke and transient ischemic attack (TIA)


    Stroke blood vessel



    In an exploratory subgroup analysis of the THALES trial, Wang Yongjun of Capital Medical University and others described the effectiveness of DAPT with ticagrelor plus aspirin in patients with acute ischemic stroke with a baseline NIHSS score of 4 or 5 in the first 30 days And safety


    Describe the effectiveness and safety of DAPT with ticagrelor plus aspirin in patients with acute ischemic stroke with a baseline NIHSS score of 4 or 5 in the first 30 days


    Patients took ticagrelor (180 mg loading dose on day 1 and 90 mg twice daily on days 2 to 30) or placebo within 24 hours of the onset of symptoms


    Main clinical outcome: The main outcome is the time to stroke or death within 30 days




    Among patients with moderate stroke, 8 patients (0.


    In this large-scale study, it was found that compared with patients with less severe ischemic stroke, patients with moderate ischemic stroke benefited from ticagrelor plus aspirin and aspirin alone , while intracranial hemorrhage or other There is no further increase in the risk of serious bleeding events


    Compared with patients with less severe ischemic stroke, patients with moderate ischemic stroke benefit from ticagrelor plus aspirin and aspirin alone .





    Leave a message here
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.